|
||||||
Swine Flu Vaccine Additives Complex IssueVaccination Adjuvant Squalene Not In 2009 Batch, But Could Be Added
The 2009 swine and seasonal flu vaccines don't contain squalene, an additive linked to autoimmune issues. In the event of a pandemic, it could be added. Stay informed.
As concern over the swine and seasonal flu increases, some vaccination safety groups feel government and drug companies are promoting panic and putting profit above public safety. The issue of vaccination additives is complex and requires consumers to conduct their own balanced research. Anyone considering the swine and seasonal flu vaccines may want to consult three information sources before deciding for or against getting the vaccine:
Flu Vaccine Additives: Helpful or Harmful Money Makers?Adjuvants are sometimes added to vaccines to elicit a long-lasting and heightened immune response in the body. Super charging the immune response allows vaccine makers to drastically reduce the amount of the viral antigen needed. "Less vaccine required per person," says leading natural health writer Dr. Joseph Mercola, "means more individual doses available for mass vaccination campaigns. Coincidentally, this is exactly the goal of government and the pharmaceutical companies who stand to make millions from their vaccine." Adjuvants such as aluminum and more notably, squalene, are under fire by vaccine watch dog organizations much like the mercury-containing preservative Thimerosal has been. Thimerosal was removed from children's vaccines by 2001 but remains in many flu vaccinations. Adjuvanted vaccines with aluminum are approved in the United States against diphtheria, tetanus, hepatitis A, and hepatitis B. Squalene however, is not. According to Australian scientist Viera Scheibner, Ph.D., "The chemical nature of adjuvants, their mode of action and their reactions are highly variable in terms of how they affect the immune system and how serious their adverse effects are due to the resultant hyperactivation of the immune system. “ Squalene Adjuvant Safety in VaccinationsSqualene is an oil-based adjuvant produced by the liver that helps metabolize cholesterol and combat physical injuries. It is safe in its natural state and can even be consumed in olive oil for its health benefits. Yet when squalene is injected, the body attacks the "foreign" invader, going after the squalene in the body as well as the squalene in the vaccine. The result can lead to autoimmune reactions. A study published in the 2000 American Journal of Pathology found that squalene "can trigger chronic, immune-mediated joint-specific inflammation.” Results raised questions about adjuvants and their role in rheumatoid arthritis and chronic inflammatory diseases. Squalene in Gulf War Anthrax VaccinationsResearchers in a Tulane study published in Experimental Molecular Pathology found that “the substantial majority (95%) of overtly ill deployed Gulf War Syndrome (GWS) patients had antibodies to squalene. All (100%) GWS patients immunized for service in Desert Shield/Desert Storm who did not deploy, but had the same signs and symptoms as those who did deploy, had antibodies to squalene.” The World Health Organization (WHO) and the Department of Defense deny squalene was used in the anthrax vaccines administered to the Persian Gulf War military personnel, or in vaccines involved in the Anthrax Vaccine Immunization Program (AVIP). "It is now known that squalene was not added to the vaccines administered to these veterans, and technical deficiencies in the report suggesting an association have been published." (WHO website). Swine Flu Vaccines and Squalene: Pandemic Emergency Use OnlyTo date, the Food and Drug Administration has not approved a squalene adjuvanted vaccine for influenza. That may change. Health and Human Services (HHS) issued a statement in July 2009 announcing that HHS "will commit $884 million to purchase additional supplies of two key ingredients for potential H1N1 vaccine to further prepare the nation for a potential resurgence of the 2009 H1N1 virus. The funds will be used to place additional orders for bulk H1N1 antigen and adjuvant on existing contracts with Sanofi Pasteur, MedImmune, GlaxoSmithKline and Novartis." The government appears to be bypassing the rigorous clinical trials the FDA requires to release new substances to the marketplace. In preparation for a pandemic swine flu emergency, where mass vaccines would be needed quickly, the U.S. is testing the squalene adjuvant on 25% of 12,000 Americans who agreed to serve as paid clinical trial participants for the H1N1 vaccine. Yet, even the government questions the safety of their own squalene adjuvants. The National Vaccine Program Office, in a 2009 presentation on the vaccine and immunizations strategies for the novel H1N1 virus wrote, "Safety: Since new technologies are involved in the production of some pandemic vaccines, which have not yet been extensively evaluated for their safety in certain groups, it is very important to implement post-marketing surveillance of the highest possible quality." In other words, the government is prepared to closely monitor vaccine injuries after they occur. Current Swine Flu VaccinesWhile the current batch of swine and seasonal flu vaccines do not contain adjuvants, the multi-dose vials of most inactivated (injected) H1N1 swine flu vaccines do contain small amounts of the preservative Thimerosal. The live virus nasal spray will not contain Thimerosal or the unlicensed adjuvant that may be later added to inactivated H1N1 vaccines. The vaccine additive issue remains dynamic and complex. Anyone interested in learning about flu vaccinations should follow a three-pronged decision approach: Consult with a doctor, review government website recommendations, and refer to credible vaccine safety consumer advocacy websites. Resources: Government & World Health Organization approved vaccination safety groups Consumer vaccination safety advocacy groups Tamiflu Not Best Option to Treat Flu Sources: Mercola, Joseph, DO., "Squalene: The Swine Flu Vaccine's Dirty Little Secret Exposed," July 2009. Scheibner, Vera, Ph.D, "Adverse Effects of Adjuvants in Vaccines," http://www.whale.to/vaccines/scheibner_a.html, 2000. Calrson, Barbo C, et al, "The Endogenous Adjuvant Squalene Can Induce a Chronic T-Cell-Mediated Arthritis in Rats," American Journal of Pathology, June 2000. Asa, PB, et al.,"Antibodies to squalene in Gulf War syndrome," Experimental and Molecular Pathology, February 2000. West, Edda, "A Glimpse into the Scary World of Vaccine Adjuvants," Vaccination Review Awareness Network Newsletter, Winter, 2005. Newborg, Herb, "Swine Flu Scare: It’s All about The Adjuvant!" Accessed Online: October 8th, 2009. National Vaccine Program Office,"United States Vaccine and Immunization Strategy for Novel H1N1 Virus: Communication Challenges," Presentation, July 7, 2009.
The copyright of the article Swine Flu Vaccine Additives Complex Issue in Public Healthcare Issues is owned by Laura Owens. Permission to republish Swine Flu Vaccine Additives Complex Issue in print or online must be granted by the author in writing.
Comments
Oct 17, 2009 11:26 AM
vaccineswork :
Oct 18, 2009 11:49 AM
Laura Owens :
Oct 22, 2009 10:16 AM
Guest :
Oct 22, 2009 1:23 PM
Laura Owens :
4 Comments
|
||||||
|
|
||||||
|
|
||||||